EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

More than Three Decades of Bm86: What We Know and Where to Go

Laura Jane Bishop, Christian Stutzer iD, Christine Maritz-Olivier

Pathogens · 22.08.2023 · 12 (9) · 1071

DOI: 10.3390/pathogens12091071 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathogens, online erschienen am 22.08.2023. Verfasst von Laura Jane Bishop und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Genetics and Microbiology, Faculty of Natural and Agricultural Sciences, University of Pretoria, Pretoria 0083, South Afr…. Hauptthemen laut MEDLINE: Vaccines, Rhipicephalus, Tick-Borne Diseases, Tick Infestations. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 233 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tick and tick-borne disease control have been a serious research focus for many decades. In a global climate of increasing acaricide resistance, host immunity against tick infestation has become a much-needed complementary strategy to common chemical control. From the earliest acquired resistance studies in small animal models to proof of concept in large production animals, it was the isolation, characterization, and final recombinant protein production of the midgut antigen Bm86 from the Australian cattle tick strain of Rhipicephalus (Boophilus) microplus (later reinstated as R. (B.) australis) that established tick subunit vaccines as a viable alternative in tick and tick-borne disease control. In the past 37 years, this antigen has spawned numerous tick subunit vaccines (either Bm86-based or novel), and though we are still describing its molecular structure and function, this antigen remains the gold standard for all tick vaccines. In this paper, advances in tick vaccine development over the past three decades are discussed alongside the development of biotechnology, where existing gaps and future directives in the field are highlighted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VaccinesRhipicephalusTick-Borne DiseasesTick InfestationsAnimalsHumansVaccines, SubunitVaccine DevelopmentMembrane GlycoproteinsRecombinant Proteins

Stichwörter der Autor:innen

Bm86antigentickvaccinevaccine development

Substanzen

VaccinesBM86 protein, BoophilusVaccines, SubunitMembrane GlycoproteinsRecombinant Proteins

Autor:innen und Institutionen

  • Department of Biochemistry, Genetics and Microbiology, Faculty of Natural and Agricultural Sciences, University of Pretoria, Pretoria 0083, South Africa.

ORCID-Profile: Christian Stutzer

Zitieren

APA

Bishop, L. J., Stutzer, C., & Maritz-Olivier, C. (2023). More than Three Decades of Bm86: What We Know and Where to Go. Pathogens, 12(9), 1071. https://doi.org/10.3390/pathogens12091071

Vancouver

Bishop LJ, Stutzer C, Maritz-Olivier C. More than Three Decades of Bm86: What We Know and Where to Go. Pathogens. 2023;12(9):1071. doi:10.3390/pathogens12091071

BibTeX
@article{Bishop2023,
  author = {Bishop, Laura Jane and Stutzer, Christian and Maritz-Olivier, Christine},
  title = {More than Three Decades of Bm86: What We Know and Where to Go},
  journal = {Pathogens},
  year = {2023},
  volume = {12},
  number = {9},
  pages = {1071},
  doi = {10.3390/pathogens12091071}
}
Kostenlos starten →